Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Schering Sales Force Reduction Shows “Changing Dynamics” In U.S. Market

Executive Summary

Schering-Plough's sales force restructuring is a clear indication that the era of escalating field forces is coming to an end

You may also be interested in...



Schering Sales Force Recruitment Is 80% Complete; Morale Remains High

Recruitment for Schering-Plough's sales force expansion is 80% complete, Global Pharmaceutical President Carrie Cox told investors during a year-end conference call Jan. 26

Schering Sales Force Recruitment Is 80% Complete; Morale Remains High

Recruitment for Schering-Plough's sales force expansion is 80% complete, Global Pharmaceutical President Carrie Cox told investors during a year-end conference call Jan. 26

The 10% Solution: Roche Cuts U.S. Sales Force, Schering Reduces Payroll

Roche is cutting its U.S. sales force by 10% before the end of the year

Related Content

UsernamePublicRestriction

Register

PS040099

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel